Israel China Biotechnology Stock Current Ratio
ICB Stock | 620.00 14.20 2.34% |
Israel China Biotechnology fundamentals help investors to digest information that contributes to Israel China's financial success or failures. It also enables traders to predict the movement of Israel Stock. The fundamental analysis module provides a way to measure Israel China's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Israel China stock.
Israel |
Israel China Biotechnology Company Current Ratio Analysis
Israel China's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Competition |
In accordance with the recently published financial statements, Israel China Biotechnology has a Current Ratio of 0.0 times. This is 100.0% lower than that of the Healthcare sector and about the same as Health Care Equipment & Supplies (which currently averages 0.0) industry. The current ratio for all Israel stocks is 100.0% higher than that of the company.
Israel Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Israel China's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Israel China could also be used in its relative valuation, which is a method of valuing Israel China by comparing valuation metrics of similar companies.Israel China is currently under evaluation in current ratio category among its peers.
Israel Fundamentals
Return On Equity | -2.2 | |||
Return On Asset | -0.38 | |||
Operating Margin | 135.33 % | |||
Current Valuation | 18.2 M | |||
Shares Outstanding | 3.75 M | |||
Shares Owned By Insiders | 53.76 % | |||
Price To Book | 6.89 X | |||
Price To Sales | 5.60 X | |||
Revenue | 83 K | |||
Gross Profit | (224 K) | |||
EBITDA | (11.16 M) | |||
Net Income | (11.93 M) | |||
Book Value Per Share | 0.51 X | |||
Cash Flow From Operations | (4.34 M) | |||
Earnings Per Share | (2.02) X | |||
Beta | 1.18 | |||
Market Capitalization | 19.47 M | |||
Total Asset | 8.34 M | |||
Z Score | -3.3 | |||
Net Asset | 8.34 M |
About Israel China Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Israel China Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Israel China using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Israel China Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Israel Stock
Israel China financial ratios help investors to determine whether Israel Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Israel with respect to the benefits of owning Israel China security.